Archives
Influenza Hemagglutinin (HA) Peptide: Precision Tag for A...
Influenza Hemagglutinin (HA) Peptide: Precision Tag for Advanced Protein Workflows
Overview: Principle and Versatility of the HA Tag Peptide
The Influenza Hemagglutinin (HA) Peptide (sequence: YPYDVPDYA) is a synthetic, nine-amino acid epitope tag derived from the human influenza hemagglutinin protein. As a molecular biology peptide tag, it has become foundational for the detection, purification, and functional analysis of fusion proteins in diverse biomedical research contexts. Its compact size, high specificity for anti-HA antibodies, and excellent solubility in DMSO (≥55.1 mg/mL), ethanol (≥100.4 mg/mL), and water (≥46.2 mg/mL) make it a premier choice for demanding experimental setups.
Within the landscape of protein-protein interaction studies, immunoprecipitation with Anti-HA antibody, and exosome research, the HA tag peptide offers a unique combination of affinity, ease of use, and compatibility with a broad array of buffers and purification formats. The product’s high purity (>98% by HPLC and MS) guarantees reproducibility and minimal background, supporting robust signal detection and downstream analyses.
Step-by-Step Protocol Enhancements for Optimized HA Tag Workflows
1. Construct Design and Expression
Begin by fusing the HA tag DNA sequence (coding for YPYDVPDYA) in-frame at the N- or C-terminus of the protein of interest. The small size of the hemagglutinin tag minimizes disruption to protein folding or function. Ensure codon optimization for your expression system, and verify HA tag nucleotide sequence integration by sequencing.
2. Cell Lysis and Sample Preparation
Lyse cells using non-denaturing buffers compatible with protein–protein interaction preservation. The high solubility of the HA peptide allows easy adjustment of buffer composition for maximal protein recovery. For downstream immunoprecipitation, pre-clear lysates to reduce non-specific binding.
3. Immunoprecipitation and Competitive Elution
- Incubate clarified lysates with Anti-HA Magnetic Beads or conventional Anti-HA antibodies bound to Protein A/G resin.
- Wash beads rigorously to remove unbound proteins, leveraging the peptide’s high specificity to minimize background.
- Elute HA-tagged fusion proteins by adding excess synthetic HA peptide at concentrations typically ranging from 0.5–2 mg/mL, depending on bead capacity and target abundance. The peptide competitively binds to the Anti-HA antibody, releasing the HA-tagged protein while preserving its native conformation and activity.
- Collect eluates for downstream analyses such as SDS-PAGE, Western blot, or mass spectrometry.
For high-throughput workflows, the peptide’s robust solubility supports preparation of concentrated stock solutions, enabling rapid and reproducible processing of multiple samples in parallel.
4. Protein Detection and Quantification
After elution, detect the HA fusion protein using standard anti-HA immunoblotting protocols. The epitope tag for protein detection ensures sensitive, specific identification even in complex lysates. For quantitative interaction studies, calibrate detection using known amounts of HA peptide to enhance assay accuracy.
5. Exosome and EV Research Applications
The HA tag peptide is gaining traction in exosome research, as illustrated by recent advances in dissecting exosome biogenesis pathways (Wei et al., 2021). By tagging exosomal or endosomal proteins, researchers can monitor trafficking, cargo loading, and secretion, while the peptide enables gentle, non-denaturing recovery for proteomic or functional analysis.
Advanced Applications and Comparative Advantages
A. Fine Mapping of Protein-Protein Interactions
APExBIO’s Influenza Hemagglutinin (HA) Peptide is the gold-standard HA fusion protein elution peptide, facilitating detailed analysis of protein complexes. In studies of endocytic and exosomal pathways—such as the ESCRT-independent biogenesis outlined in Wei et al., 2021—the HA tag system enables selective pull-down and mapping of interacting partners with minimal disruption.
Compared to other epitope tags (e.g., FLAG, Myc), the HA tag offers:
- Higher solubility and ease of elution under mild conditions
- Consistent antibody performance and broad reagent compatibility
- Minimal size, reducing steric hindrance in protein complexes
For example, LABPE’s review highlights how the HA tag streamlines immunoprecipitation and purification, contrasting with larger or less soluble tags that may complicate elution or downstream analyses.
B. Exosome Research and Translational Insights
In the context of studying RAB31 and ESCRT-independent exosome pathways, as detailed in the referenced Cell Research article, the HA tag system enables selective isolation of tagged exosomal cargo or pathway regulators. This supports unbiased proteomic studies and mapping of cargo sorting mechanisms—critical for understanding disease-related vesicle signaling (AY-9944.com extends these insights by focusing on advanced applications in exosome biology).
C. Integration with Advanced Analytical Techniques
The peptide’s benchmark purity (>98%) and low endotoxin profile make it suitable for integration with high-sensitivity mass spectrometry or quantitative proteomics. This compatibility is further explored in R110-Azide-5-Isomer’s article, which discusses mechanistic and translational impacts of HA tag peptide use in signaling and metastasis research.
Troubleshooting and Optimization Tips
Maximizing Yield and Specificity
- Peptide Concentration: Optimize the amount of HA peptide used for elution. Excess peptide ensures complete competitive binding to Anti-HA antibody, but overuse may dilute target protein. Start with 1 mg/mL and titrate as needed.
- Solubility: Prepare peptide stock solutions in DMSO, ethanol, or water according to buffer compatibility and experimental requirements. For sensitive assays, filter-sterilize and aliquot stocks to prevent contamination and degradation.
- Storage: Store lyophilized peptide desiccated at -20°C. Avoid long-term storage of peptide solutions; prepare fresh stocks for each experiment to preserve integrity and activity.
- Antibody/Bead Selection: Use high-affinity Anti-HA antibodies or magnetic beads for maximal recovery. Pre-block beads with BSA or relevant serum to minimize non-specific binding.
- Washing Steps: Increase wash stringency if background is high, but avoid excessive washing that could reduce yield. The peptide's high specificity enables balance between purity and yield.
Common Issues and Solutions
- Low Elution Efficiency: Ensure peptide is fully dissolved and used at sufficient concentration. Increase incubation time with the beads during elution to enhance recovery.
- Non-Specific Bands: Pre-clear lysates and rigorously wash beads. Check for non-specific interactions by including negative controls (lysates lacking HA-tagged protein).
- Protein Degradation: Include protease inhibitors during lysis and processing. Work at 4°C to minimize enzymatic activity.
- Reproducibility: Use peptide from a reputable supplier like APExBIO, which guarantees >98% purity and validated performance, to ensure experiment-to-experiment consistency.
For more detailed troubleshooting strategies and workflow optimization, AP24534.com offers advanced protocol enhancements and comparison with alternative tags.
Future Outlook: Expanding the HA Tag Frontier
The role of the Influenza Hemagglutinin (HA) Peptide is rapidly expanding beyond traditional detection and purification. Its established performance in exosome and vesicle research, as evidenced by its application in elucidating ESCRT-independent pathways (Wei et al., 2021), sets the stage for broader adoption in signal transduction, disease biomarker discovery, and high-throughput interactome mapping.
Ongoing innovations include multiplexed tagging strategies, orthogonal purification workflows, and integration with CRISPR/Cas9 genome editing for endogenous protein tagging. The exceptional solubility and purity of APExBIO’s HA tag peptide support these advanced methodologies, enabling researchers to push the boundaries of molecular biology and translational science.
To stay at the forefront of precision proteomics and cell biology, researchers are increasingly leveraging the HA tag, its DNA and nucleotide sequences, and its compatibility with next-generation analytical platforms. As new discoveries emerge, the Influenza Hemagglutinin (HA) Peptide will remain a pivotal tool for unlocking complex biological pathways and advancing therapeutic research.
References and Further Reading:
- Influenza Hemagglutinin (HA) Peptide – APExBIO Product Page
- Wei D. et al., RAB31 marks and controls an ESCRT-independent exosome pathway, Cell Research (2021)
- Influenza Hemagglutinin (HA) Peptide: Elevating Immunoprecipitation and Protein Purification Workflows
- Influenza Hemagglutinin (HA) Peptide: Advanced Epitope Tag for Exosome Research
- Next-Gen Applications of the HA Tag Peptide in Signal Transduction
- Protocol Optimization and Comparative Advantages of the HA Tag